These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 32909410)

  • 1. [Arguments for a role of the gut microbiota in the pathophysiology of hypertension].
    Huart J; Krzesinski JM; Jouret F
    Rev Med Liege; 2020 Sep; 75(9):588-592. PubMed ID: 32909410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interplay among gut microbiota, hypertension and kidney diseases: The role of short-chain fatty acids.
    Felizardo RJF; Watanabe IKM; Dardi P; Rossoni LV; Câmara NOS
    Pharmacol Res; 2019 Mar; 141():366-377. PubMed ID: 30639376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The gut microbiota and the brain-gut-kidney axis in hypertension and chronic kidney disease.
    Yang T; Richards EM; Pepine CJ; Raizada MK
    Nat Rev Nephrol; 2018 Jul; 14(7):442-456. PubMed ID: 29760448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of gut microbiota: How it could play roles beyond the digestive system on development of cardiovascular and renal diseases.
    Suganya K; Son T; Kim KW; Koo BS
    Microb Pathog; 2021 Mar; 152():104583. PubMed ID: 33164814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbiota in kidney disease and hypertension.
    Antza C; Stabouli S; Kotsis V
    Pharmacol Res; 2018 Apr; 130():198-203. PubMed ID: 29496593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The crosstalk of gut microbiota and chronic kidney disease: role of inflammation, proteinuria, hypertension, and diabetes mellitus.
    Kanbay M; Onal EM; Afsar B; Dagel T; Yerlikaya A; Covic A; Vaziri ND
    Int Urol Nephrol; 2018 Aug; 50(8):1453-1466. PubMed ID: 29728993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut hormones and gut microbiota: implications for kidney function and hypertension.
    Afsar B; Vaziri ND; Aslan G; Tarim K; Kanbay M
    J Am Soc Hypertens; 2016 Dec; 10(12):954-961. PubMed ID: 27865823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of diet on hypertensive pathology: is there a link via gut microbiota-driven immunometabolism?
    Jama HA; Beale A; Shihata WA; Marques FZ
    Cardiovasc Res; 2019 Jul; 115(9):1435-1447. PubMed ID: 30951169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The gut microbiota and blood pressure in experimental models.
    Jama HA; Kaye DM; Marques FZ
    Curr Opin Nephrol Hypertens; 2019 Mar; 28(2):97-104. PubMed ID: 30531472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbiota metabolites: Pivotal players of cardiovascular damage in chronic kidney disease.
    Cosola C; Rocchetti MT; Cupisti A; Gesualdo L
    Pharmacol Res; 2018 Apr; 130():132-142. PubMed ID: 29518493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Connecting the immune system, systemic chronic inflammation and the gut microbiome: The role of sex.
    Rizzetto L; Fava F; Tuohy KM; Selmi C
    J Autoimmun; 2018 Aug; 92():12-34. PubMed ID: 29861127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The gut microbiome and hypertension.
    Pevsner-Fischer M; Blacher E; Tatirovsky E; Ben-Dov IZ; Elinav E
    Curr Opin Nephrol Hypertens; 2017 Jan; 26(1):1-8. PubMed ID: 27798455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GUT Microbiome-GUT Dysbiosis-Arterial Hypertension: New Horizons.
    Katsi V; Didagelos M; Skevofilax S; Armenis I; Kartalis A; Vlachopoulos C; Karvounis H; Tousoulis D
    Curr Hypertens Rev; 2019; 15(1):40-46. PubMed ID: 29895255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-chain fatty acids: a link between prebiotics and microbiota in chronic kidney disease.
    Esgalhado M; Kemp JA; Damasceno NR; Fouque D; Mafra D
    Future Microbiol; 2017 Nov; 12():1413-1425. PubMed ID: 29027814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Gut microbiota and immune crosstalk in metabolic disease].
    Burcelin R
    Biol Aujourdhui; 2017; 211(1):1-18. PubMed ID: 28682223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fecal metabonomics combined with 16S rRNA gene sequencing to analyze the changes of gut microbiota in rats with kidney-yang deficiency syndrome and the intervention effect of You-gui pill.
    Chen R; Wang J; Zhan R; Zhang L; Wang X
    J Ethnopharmacol; 2019 Nov; 244():112139. PubMed ID: 31401318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut Microbiota and Renal Injury.
    Zhang L; Zhang W; Nie J
    Adv Exp Med Biol; 2020; 1238():93-106. PubMed ID: 32323182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Gut Microbiota in Pulmonary Arterial Hypertension.
    Wu P; Zhu T; Tan Z; Chen S; Fang Z
    Front Cell Infect Microbiol; 2022; 12():812303. PubMed ID: 35601107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut Microbiome over a Lifetime and the Association with Hypertension.
    Yano Y; Niiranen TJ
    Curr Hypertens Rep; 2021 Mar; 23(3):15. PubMed ID: 33686539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beyond gut feelings: how the gut microbiota regulates blood pressure.
    Marques FZ; Mackay CR; Kaye DM
    Nat Rev Cardiol; 2018 Jan; 15(1):20-32. PubMed ID: 28836619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.